Back to Search Start Over

TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells

Authors :
Olivier Moncorgé
Sarah Maillet
Jean-Philippe Herbeuval
Nikaïa Smith
Joanne Edouard
Ghizlane Maarifi
Nathalie J. Arhel
Jean-Pierre Levraud
Frédéric Sohm
Georges Lutfalla
Fabien Blanchet
Sébastien Nisole
Célia Chamontin
Institut de Recherche en Infectiologie de Montpellier (IRIM)
Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
Universitätsklinikum Ulm - University Hospital of Ulm
Equipe Chimie et Biologie
Modélisation et Immunologie pour la Thérapie (CBMIT)
Université Paris Descartes - Paris 5 (UPD5)-Université Paris Descartes - Paris 5 (UPD5)
Animaux Modèles Aquatiques : ingéniérie GENétique (AMAGEN)
Institut National de la Recherche Agronomique (INRA)-Centre National de la Recherche Scientifique (CNRS)
Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques (LCBPT - UMR 8601)
Université Paris Descartes - Paris 5 (UPD5)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)
Dynamique des interactions membranaires normales et pathologiques (DIMNP)
Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université Montpellier 1 (UM1)
Macrophages et Développement de l’Immunité
Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Funding: This work was supported by Labex EpiGenMed, an Investissements d’avenir program (ANR-10-LABX-12-01 to N.J.A. and S.N.)
the Agence National de la Recherche sur le SIDA et les Hépatites virales, ANRS (AO2017-1 to J.-P.H.)
the European Community’s Seventh Framework Program (FP7- PEOPLE-2011-ITN) under the Marie-Curie Initial Training Network FishForPharma (PITN-GA-2011-289209 to G.L.)
the European Community’s H2020 Program Marie-Curie Innovative Training Network ImageInLife (721537 to G.L. and J.-P.L.)
the Agence Nationale de la Recherche (ANR-16-CE20-0002-03 and ANR-10-MDI-009 to J.-P.L.)
and the Région Occitanie (REPERE2017ImageInLife to G.L.). G.M. (AO2018-2), N.S. (AO2016-1), O.M. (AO2017-1), and S.M. (AO2017-2) were supported by grants from the ANRS. This work received help and expertise from TACGene, which is supported by the program Investissement d’avenir TEFOR (ANR-II-INSB-0014). N.S. acknowledges support from the European Molecular Biology Organization EMBO for Fellowship (LT-834-2017), the start-up funding program 'Baustein' of the Medical Faculty of Ulm University (LSBN.0147), and the Deutsche Forschungsgemeinschaft DFG (SM 544/1-1).
ANR-10-LABX-0012,EpiGenMed,From Genome and Epigenome to Molecular Medicine: turning new paradigms in biology into the therapeutic strategies of tomorrow(2010)
ANR-16-CE20-0002,Fish-RNAvax,Vaccins ARN éco-compatibles pour l'induction de réponses immunitaires protectrices chez le poisson d'élevage(2016)
ANR-10-MIDI-0009,ZebraFlam,Signaux et cellules de la réponse inflammatoire: suivi en temps réel chez un vertébré entier, le danio zébré(2010)
ANR-11-INBS-0014,TEFOR,Transgenèse pour les Etudes Fonctionnelles sur les Organismes modèles(2011)
European Project: 289209,EC:FP7:PEOPLE,FP7-PEOPLE-2011-ITN,FISHFORPHARMA(2012)
European Project: 721537,ImageInLife(2017)
Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)
Université Paris Descartes - Paris 5 (UPD5)-Centre National de la Recherche Scientifique (CNRS)
ANR-10-LABX-0012/10-LABX-0012,EpiGenMed,From Genome and Epigenome to Molecular Medicine: turning new paradigms in biology into the therapeutic strategies of tomorrow(2010)
ANR: 11-INBS-0014,TEFOR,Transgenèse pour les Etudes Fonctionnelles sur les Organismes modèles(2011)
Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)
Source :
Science Advances, Science Advances, American Association for the Advancement of Science (AAAS), 2019, 5 (11), pp.eaax3511. ⟨10.1126/sciadv.aax3511⟩, Science Advances, 2019, 5 (11), pp.eaax3511. ⟨10.1126/sciadv.aax3511⟩
Publication Year :
2019
Publisher :
HAL CCSD, 2019.

Abstract

TRIM8 and Pin1 oppositely control IRF7-induced interferon production.<br />Plasmacytoid dendritic cells (pDCs) play a crucial role in antiviral innate immunity through their unique capacity to produce large amounts of type I interferons (IFNs) upon viral detection. Tripartite motif (TRIM) proteins have recently come forth as important modulators of innate signaling, but their involvement in pDCs has not been investigated. Here, we performed a rationally streamlined small interfering RNA (siRNA)–based screen of TRIM proteins in human primary pDCs to identify those that are critical for the IFN response. Among candidate hits, TRIM8 emerged as an essential regulator of IFN regulatory factor 7 (IRF7) function. Mechanistically, TRIM8 protects phosphorylated IRF7 (pIRF7) from proteasomal degradation in an E3 ubiquitin ligase–independent manner by preventing its recognition by the peptidyl-prolyl isomerase Pin1. Our findings uncover a previously unknown regulatory mechanism of type I IFN production in pDCs by which TRIM8 and Pin1 oppositely regulate the stability of pIRF7.

Details

Language :
English
ISSN :
23752548
Database :
OpenAIRE
Journal :
Science Advances, Science Advances, American Association for the Advancement of Science (AAAS), 2019, 5 (11), pp.eaax3511. ⟨10.1126/sciadv.aax3511⟩, Science Advances, 2019, 5 (11), pp.eaax3511. ⟨10.1126/sciadv.aax3511⟩
Accession number :
edsair.doi.dedup.....7c12764eb916b52f5082cd4ed9ec0647